EUVIMEDObjevte EUVIMED
Open access

Lymphatic-draining nanoparticles deliver Bay K8644 payload to lymphatic vessels and enhance their pumping function

Lauren F Sestito iD, Kim H T To, Matthew T Cribb iD, Paul A Archer iD, Susan N Thomas iD, J Brandon Dixon iD

Science Advances · 2023

DOI: 10.1126/sciadv.abq0435 ↗

At a glance

Journal article in Science Advances, 2023. Written by Lauren F Sestito and 5 co-authors. Institution: Wallace H. Coulter School of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA. Major MEDLINE topics: Lymphatic Vessels. Cited 22 times so far (Crossref); 71 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS, NCI NIH HHS, NIBIB NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Dysfunction of collecting lymphatic vessel pumping is associated with an array of pathologies. S-(−)-Bay K8644 (BayK), a small-molecule agonist of L-type calcium channels, improves vessel contractility ex vivo but has been left unexplored in vivo because of poor lymphatic access and risk of deleterious off-target effects. When formulated within lymph-draining nanoparticles (NPs), BayK acutely improved lymphatic vessel function, effects not seen from treatment with BayK in its free form. By preventing rapid drug access to the circulation, NP formulation also reduced BayK’s dose-limiting side effects. When applied to a mouse model of lymphedema, treatment with BayK formulated in lymph-draining NPs, but not free BayK, improved pumping pressure generated by intact lymphatic vessels and tissue remodeling associated with the pathology. This work reveals the utility of a lymph-targeting NP platform to pharmacologically enhance lymphatic pumping in vivo and highlights a promising approach to treating lymphatic dysfunction.

Subjects

MeSH terms (MEDLINE)

Lymphatic VesselsMiceAnimals3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterDisease Models, AnimalPressure

Substances

3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester

Authors and institutions

  • Wallace H. Coulter School of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA 30332, USA.
  • Department of Mechanical Engineering and Bioengineering, Valparaiso University, 1900 Chapel Dr, Valparaiso, IN 46383, USA.
  • George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA.
  • Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA 30332, USA.
  • Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.

ORCID profiles: Lauren F Sestito, Matthew T Cribb, Paul A Archer, Susan N Thomas, J Brandon Dixon

Funding

  • NHLBI NIH HHS
  • NCI NIH HHS
  • NIBIB NIH HHS

Cite

APA

Sestito, L. F., To, K. H. T., Cribb, M. T., Archer, P. A., Thomas, S. N., & Dixon, J. B. (2023). Lymphatic-draining nanoparticles deliver Bay K8644 payload to lymphatic vessels and enhance their pumping function. Science Advances. https://doi.org/10.1126/sciadv.abq0435

Vancouver

Sestito LF, To KHT, Cribb MT, Archer PA, Thomas SN, Dixon JB. Lymphatic-draining nanoparticles deliver Bay K8644 payload to lymphatic vessels and enhance their pumping function. Science Advances. 2023. doi:10.1126/sciadv.abq0435

BibTeX
@article{Sestito2023,
  author = {Sestito, Lauren F and To, Kim H T and Cribb, Matthew T and Archer, Paul A and Thomas, Susan N and Dixon, J Brandon},
  title = {Lymphatic-draining nanoparticles deliver Bay K8644 payload to lymphatic vessels and enhance their pumping function},
  journal = {Science Advances},
  year = {2023},
  doi = {10.1126/sciadv.abq0435}
}
Start for free →